OBESE CASTRATION-RESISTANT PROSTATE CANCER PATIENTS MAY BE AT A LOWER RISK OF METASTASIS AND ALL-CAUSE MORTALITY: RESULTS FROM THE SEARCH DATABASE

被引:0
|
作者
Vidal, Adriana C.
Howard, Lauren E.
Kane, Christopher J.
Terris, Martha K.
Aronson, William J.
Cooperberg, Matthew R.
Amling, Christopher L.
Freedland, Stephen J.
机构
来源
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词
D O I
10.1016/j.juro.2015.02.874
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP14-12
引用
收藏
页码:E155 / E155
页数:1
相关论文
共 50 条
  • [1] Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database
    Vidal, Adriana C.
    Howard, Lauren E.
    de Hoedt, Amanda
    Kane, Christopher J.
    Terris, Martha K.
    Aronson, William J.
    Cooperberg, Matthew R.
    Amling, Christopher L.
    Freedland, Stephen J.
    BJU INTERNATIONAL, 2018, 122 (01) : 76 - 82
  • [2] Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH
    Moreira, Daniel M.
    Howard, Lauren E.
    Sourbeer, Katharine N.
    Amarasekara, Hiruni S.
    Chow, Lydia C.
    Cockrell, Dillon C.
    Pratson, Connor L.
    Hanyok, Brian T.
    Aronson, William J.
    Kane, Christopher J.
    Terris, Martha K.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Freedland, Stephen J.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (01) : 60 - 66
  • [4] PREDICTORS OF SKELETAL RELATED EVENTS AND OVERALL MORTALITY IN MEN WITH METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE
    Tablazon, Ingrid Lorese
    Howard, Lauren
    De Hoedt, Amanda
    Aronson, William
    Kane, Christopher
    Amling, Christopher
    Cooperberg, Matthew
    Terris, Martha
    Freedland, Stephen
    Williams, Stephen
    JOURNAL OF UROLOGY, 2019, 201 (04): : E499 - E499
  • [5] Race does not predict skeletal-related events and all-cause mortality in men with castration-resistant prostate cancer
    Patel, Devin N.
    Howard, Lauren E.
    De Hoedt, Amanda M.
    Amling, Christopher L.
    Aronson, William J.
    Cooperberg, Matthew R.
    Kane, Christopher J.
    Klaassen, Zachary W.
    Terris, Martha K.
    Freedland, Stephen J.
    CANCER, 2020, 126 (14) : 3274 - 3280
  • [6] SERUM LIPID PROFILE AT TIME OF ANDROGEN DEPRIVATION THERAPY AND RISK OF CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE
    Dambal, Shweta
    Howard, Lauren
    Allott, Emma
    Aronson, William
    Kane, Christopher
    Amling, Christopher
    Cooperberg, Matthew
    Terris, Martha
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2018, 199 (04): : E262 - E263
  • [7] A drug comorbidity index to predict all-cause mortality in men with castration resistant prostate cancer
    Fallara, G.
    Gedeborg, R.
    Bill-Axelson, A.
    Garmo, H.
    Stattin, P.
    EUROPEAN UROLOGY, 2021, 79 : S1199 - S1200
  • [8] Serum Lipids prior to Starting Androgen Deprivation Therapy and Risk of Castration Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database
    Dambal, Shweta
    Howard, Lauren E.
    Allott, Emma H.
    Aronson, William J.
    Kane, Christopher J.
    Amling, Christopher L.
    Cooperberg, Matthew R.
    Terris, Martha K.
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2020, 203 (01): : 120 - 126
  • [9] Are Metabolically Normal but Obese Individuals at Lower Risk for All-Cause Mortality?
    Kuk, Jennifer L.
    Ardern, Chris I.
    DIABETES CARE, 2009, 32 (12) : 2297 - 2299
  • [10] Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database
    Nik-Ahd, Farnoosh
    Howard, Lauren E.
    Eisenberg, Adva T.
    Aronson, William J.
    Terris, Martha K.
    Cooperberg, Matthew R.
    Amling, Christopher L.
    Kane, Christopher J.
    Freedland, Stephen J.
    CANCER, 2019, 125 (16) : 2861 - 2867